Melita Sun Jung insider trades
Open-market stock purchases and sales by Melita Sun Jung, Chief Business Officer at Terns Pharmaceuticals, Inc, from SEC Form 4 filings since Feb 7, 2023.
Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +140%.
Recent trades
No open-market trades in the last 12 months.